Add BrightSurf on Google Email

Wound-healing waves

Cells utilize long-distance traveling waves in a self-organized manner to close wounds, guided by intricate interplay of cell movement, sensing, and protein activation. This coupled system enables robust communication of direction over large distances, promoting coordinated behavior for healing and growth.

Well-known molecule not found in cancer cells after all

Researchers from Aarhus University discovered that a circular RNA molecule, ciRS-7, is actually not found in cancer cells but contributes to cancer development through the tumor's microenvironment. This finding challenges previous conclusions and highlights the importance of spatial analyses of patient tumors.

SourceAarhus University·JournalNature Communications·DateSep 24, 2020

The web of death

Scientists have developed a new method to combat cancer by using molecular fibers that target the acidic and reactive environment of cancer cells. The approach has shown promising results in laboratory tests, with cancer cells dying within four hours.

SourceMax Planck Institute for Polymer Research·JournalJournal of the American Chemical Society·DateSep 10, 2020

Attacking tumors directly on identification

Scientists have identified a promising new system to attack tumors directly by combining a small biomolecule with a toxic metal complex. The molecule's luminescent properties allow for detection within cells and demonstrate its toxic effect, paving the way for further research into this innovative theranostic system.

Using tattoo ink to find cancer

Using tattoo ink and food dyes, researchers have developed new imaging contrast agents that can illuminate cancers, allowing for better differentiation between cancer cells and normal adjacent cells. This breakthrough aims to improve early cancer detection and localization.

SourceUniversity of Southern California·JournalBiomaterials Science·DateSep 2, 2020

Cellular energy audit reveals energy producers and consumers

Scientists at Gladstone Institutes have performed a massive cellular energy audit to understand how cells regulate ATP levels. They identified genes and proteins that can be targeted to manipulate cellular energy and treat disease, including neurodegenerative disorders and cancer. The study reveals new pathways for boosting cellular en...

SourceGladstone Institutes·JournalNature Communications·DateAug 28, 2020

Excellent research results for CAR-T Cell therapy against Hodgkin lymphoma

A clinical trial led by UNC Lineberger Comprehensive Cancer Center found CAR-T cell therapy to be highly active and safe in patients with relapsed/refractory Hodgkin lymphoma. The treatment resulted in a complete disappearance of tumor in the majority of patients and had an overall survival rate of 94% one year after treatment.

SourceUNC Lineberger Comprehensive Cancer Center·JournalJournal of Clinical Oncology·DateJul 23, 2020

MU advances chemotherapy-free treatment for cancer in animals and humans

Researchers at MU successfully treated bone cancer in dogs with a vaccine that stimulates the immune system against abnormal proteins specific to the patient's tumor. The treatment outperformed chemotherapy, resulting in over 400 days of cancer survival for dogs compared to about 270 days for those receiving traditional chemotherapy.

SourceUniversity of Missouri-Columbia·JournalJournal of Veterinary Internal Medicine·DateJul 17, 2020

Host cell fusion in bacteria infection alarms immune system, causing host cell destruction

The study reveals that Burkholderia pseudomallei infection sets off a series of events that provoke the host's immune system, causing infected cells to self-destruct. The researchers found that abnormal cell fusion stimulates the type 1 interferon signaling pathway, leading to autophagy and cell death.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalProceedings of the National Academy of Sciences·DateJul 7, 2020

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells

Researchers have successfully engineered T-cells to target a variety of solid-tumor cancer cells in humans and mice using CAR-T therapy. The new approach broadens the potential targets by recognizing proteins with short sugar chains attached, which are often mutated in cancer cells.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalProceedings of the National Academy of Sciences·DateJun 29, 2020